Youovop, J., Takuissu, G., Minoue, R., Nwang, F., Adegboyega, M., Makamwe, I., & Oben, J
We look forward to working with regulators as they evaluate this first-of-its-kind medicine." In TRIUMPH-2, all three studied doses of retatrutide (4 mg, 9 mg, and 12 mg) delivered substantial weight loss and improved glycemic control at 80 weeks in adults with type 2 diabetes and obesity or overweight
GLP-1RA drugs activate receptors in the brain that cause these side effects, but over time the body and mind adapt and the issues often diminish
She had already witnessed the positive effect of these medications on diabetes management in the years prior to their approval for weight loss and was excited to be able to offer them to her patients who have struggled for years with obesity